Tech Stocks emergin...
Health Care: Drugs
NuPathe Inc. (PATH: NASDAQ)
$2.79 0.01 | 0.36%
06/18/13 - 04:00 PM ET
Latest Dividend:0.00
Latest Dividend Yield:0.00%
Dividend Ex-Date:12/31/69
Price Earnings Ratio:n/a
Price Earnings Comparisons:
| PATH | Sector Avg. | S&P 500 |
|---|---|---|
| n/a | 0.00 | 17.70 |
Price Performance History (% change):
| 3 Mo | 1 Yr | 3 Yr |
|---|---|---|
| -19.65 | -16.27 | 0.00 |
| GROWTH | 12 Mo | 3 Yr | CAGR |
|---|---|---|---|
| Revenue | 0.00 | 0.00 | |
| Net Income | 0.00 | 0.00 | |
| EPS | 0.00 | 0.00 |
Earnings for PATH:
| EBITDA | -21.00 |
| REVENUE | 0.00 |
Average Earnings Estimates
| Qtr (06/13) | Qtr (09/13) | FY (12/13) | FY (12/14) | |
|---|---|---|---|---|
| Average Estimate | $-0.19 | $-0.19 | $-1.23 | $-0.75 |
| Number of Analysts | 4 | 4 | 4 | 4 |
| High Estimate | $-0.15 | $-0.16 | $-1.12 | $-0.28 |
| Low Estimate | $-0.25 | $-0.25 | $-1.43 | $-1.33 |
| Prior Year | $-0.42 | $-0.42 | $-2.40 | $-1.23 |
| Growth Rate (Year over Year) | 55.36% | 54.17% | 48.75% | 39.02% |
Portfolios with PATH
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorDrugs Facing FDA Approval i...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorEarnings Short Squeeze Play...
- ContributorUnder-$10 Setting Up To Tra...
- UserSMITTY
- ContributorHot Biotech Trades for Seco...
- Contributor9 Health Care Stocks With 1...
Latest PATH Headlines from TheStreet
- 4 Health Care Stocks Under $10 to Watch 04.16.13 | 03:04 pm
- 5 Under-$10 Stocks Primed to Trade Higher 12.20.12 | 12:12 pm
- 2013 FDA Drug Approval Decision Calendar 12.19.12 | 09:12 am
- First 90 Days of 2013 Are Live or Die For These Biotech Stocks 11.19.12 | 09:11 am
- 5 Biotech Stocks Under $5 Blasting Off 08.16.12 | 03:08 pm
- NuPathe Management Discusses Q2 2012 Results - Earnings Call Transcript 08.14.12 | 02:08 pm
- 4 Stocks Under $5 Making Big Moves 07.17.12 | 12:07 pm
- 8 Stocks Under $10 Moving Higher 02.08.12 | 02:02 pm
- 11 Stocks to Watch: NuPathe, Universal Display 08.30.11 | 08:08 am
- FDA Rejects NuPathe Migraine Patch 08.30.11 | 06:08 am
Press Releases for PATH
- Safeguard Scientifics Announces Second Quarter 2011 Financial Results - Business Wire 07.27.11 | 06:07 am
Partner Headlines for PATH
- Pre-Market Earnings Report for March 26, 2013 : NEOG, PLCE, PATH - NASDAQ 03.25.13 | 08:03 pm
- Morning Market Losers - Benzinga 09.26.12 | 09:09 am
- 7 Biotech Stocks Being Snapped Up By Insiders - Seeking Alpha 03.16.12 | 05:03 pm
- Why Antares Pharma Should Be On Your List For Long-Term Investment - Seeking Alpha 03.16.12 | 08:03 am
- NuPathe Announces Allowance of U.S. Patent Application for NP202 - Benzinga 02.29.12 | 04:02 pm
- Nupathe's Zelrix Going Down A Path With Multiple Headwinds - Seeking Alpha 12.09.11 | 09:12 am
- 5 Healthcare Stocks To Consider - Seeking Alpha 09.01.11 | 08:09 am
- Mid-Day Update: US Indexes Recover from Red; Consumer Confidence Data Still Weighs - NASDAQ 08.30.11 | 04:08 pm
- Stocks Recover from Consumer Confidence Data-Induced Slump; Commodities Trending Higher - NASDAQ 08.30.11 | 04:08 pm
- Morning Market Losers - Benzinga 08.30.11 | 09:08 am
